Glenmark India

Key therapeutic categories

  • Dermatology
  • Respiratory
  • Cardiology
  • Diabetes
  • Oncology
  • Anti-Infective

Our journey in the Indian market began in 1977. Today, we are recognized as a leading player in the Indian Pharma sector with a robust portfolio of over 320 successful branded generics products. Our consistent ranking among the Top - 20 fastest growing Pharma companies, further augments our vision and the commitment to create a ‘new way for a new world’.

Our strategy in India has been to capitalize on the first-mover advantage by making an early entry into new high-growth therapy segments, which is driven by developing strong brands across core therapy categories, and the introduction of new products on a regular basis. 

Our branded formulations business in India focuses on high growth and large therapy categories such as dermatology, respiratory, cardiovascular, anti-diabetic and oncology. We are also present in therapy categories of gynecology, anti-infective and gastroenterology. To strengthen our branded formulations business in India, we have organized the business into multiple divisions which focus on select therapy categories and have built a strong team of more than 3,700 medical marketing representatives. In addition to the prescription business, we also have a strong OTC business with some strong brands like VWash Plus and Candid Dusting powder added to our product portfolio.

 

To receive medical or safety information or to report a product complaint or side effect (also called an adverse event), please contact the Glenmark customer service center at: globalcustomerservice@glenmarkpharma.com or at
022-4018-9999 from 9:00AM to 6:00PM IST (Monday to Friday)